AORT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
123.8M
-1.6%
125.8M
+8.1%
116.3M
+0.3%
116.0M
+2.3%
113.4M
Cost of Revenue
47.8M
+5.7%
45.2M
+10.6%
40.9M
-4.6%
42.8M
+9.9%
39.0M
Gross Profit
76.0M
-5.6%
80.5M
+6.7%
75.4M
+3.2%
73.1M
-1.7%
74.4M
Operating Expenses
73.0M
-17.8%
88.9M
+27.6%
69.7M
+0.3%
69.5M
+6.3%
65.4M
R&D
9.8M
+8.3%
9.1M
+2.4%
8.8M
-3.1%
9.1M
+12.9%
8.1M
SG&A
63.2M
-20.8%
79.8M
+31.2%
60.8M
+7.0%
56.8M
-0.8%
57.3M
Operating Income
2.9M
+135.2%
-8364000
-244.5%
5.8M
+57.3%
3.7M
-59.3%
9.0M
EBITDA
10.3M
+736.8%
-1616000
-113.3%
12.1M
+28.5%
9.4M
-36.0%
14.8M
Net Income
-7926000
+41.3%
-13510000
-1053.4%
1.4M
-41.6%
2.4M
-62.7%
6.5M
EPS (Basic)
$-0.16
+42.9%
$-0.28
-1033.3%
$0.03
-40.0%
$0.05
-64.3%
$0.14
EPS (Diluted)
$-0.16
+42.9%
$-0.28
-1033.3%
$0.03
-40.0%
$0.05
-61.5%
$0.13
Shares (Diluted)
48.7M
+0.4%
48.5M
-2.4%
49.7M
-4.8%
52.3M
+7.2%
48.8M
Artivion (AORT) — Financials